ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 71

Subchondral Bone Turnover and Osteophyte Formation Are Key Aspects In The Progression Of Osteoarthritis and May Be Assessed and Predicted By a-CTX

Morten Asser Karsdal1, Janet L. Huebner2, Virginia Byers Kraus2, Diana J. Leeming1, Edward Coleman2, Gary E. McDaniel3, Kim M. Huffman3, Kim Henriksen1 and Anne C. Bay-jensen1, 1Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 2Medicine/Rheumatology, Duke University Medical Center, Durham, NC, 3Medicine, Duke University Medical Center, Durham, NC

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Bone, osteoarthritis and osteophytosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Cartilage and Osteoarthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Osteoarthritis (OA) is the most common form of arthritic disease. It is characterized by pathological changes in both bone and cartilage turnover as well as structure in which subchondral bone remodeling is speculated to be both an initiator and driver of OA. The aim of the current study was to evaluate a biomarker of high localized bone resorption, a-CTX, previously used for bone metastasis. OA patients were characterized by; radiographic knee OA, severity, progression and localized knee bone turnover as assessed by bone scintigraphy, a dynamic and sensitive indicator of symptomatic knee OA. 

Methods: A total of 149 participants (111 women, 38 men) were included who met ACR criteria for symptomatic OA and had the presence of Kellgren Lawrence (K/L) grade 1-4 radiographic OA in at least one knee. Late-phase bone scan images of both knees were obtained 2 hours after administration of 99mTc-MDP. The intensity of uptake was scored semi-quantitatively and summed for each joint site. Radiographic knee OA severity, based on the summed scoring of osteophytes (OST) and joint space narrowing (JSN) was assessed using the standardized OARSI radiographic atlas. Progression status was determined by calculating the sum of the change score in either JSN or OST between baseline and the 3-year follow-up assessment. The concentrations of urinary a-CTX and CTX-II were determined by ELISA and normalized to creatinine concentration. 

Results: a-CTX was related to OST formation independent of the effects of age, gender, BMI, and HRT (p=0.009). a-CTX did not correlate with severity of knee OA based on OST and JSN, but did correlate with bone turnover assessed by intensity of 99mTc-MDP uptake in the medial knee compartment. Concentrations of urinary CTX-II were strongly associated with knee OA severity based on osteophyte, intensity of total knee 99mTc-MDP uptake, and joint space narrowing. 

Conclusion: a-CTX was associated with subchondral bone turnover, and osteophyte formation, both central features of the pathogenesis of OA. CTX-II was correlated to JSN, and burden of disease as previously reported. The significant and strong association of a-CTX to bone turnover in the subchondral region suggests that this marker may be a non-invasive surrogate for active bone turnover in knee OA. Such markers may assist in the identification patients whom may benefit from strong anti-resorptives which inhibit bone and subchondral bone turnover.


Disclosure:

M. A. Karsdal,

Nordic Biosciece,

1,

Nordic Bioscience Diagnostic,

3;

J. L. Huebner,
None;

V. B. Kraus,
None;

D. J. Leeming,

Nordic Bioscience Diagnostic,

3;

E. Coleman,
None;

G. E. McDaniel,
None;

K. M. Huffman,
None;

K. Henriksen,

Nordic Bioscience Diagnostic,

3;

A. C. Bay-jensen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subchondral-bone-turnover-and-osteophyte-formation-are-key-aspects-in-the-progression-of-osteoarthritis-and-may-be-assessed-and-predicted-by-a-ctx/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology